文献
J-GLOBAL ID:200902285337972680
整理番号:09A0806914
固形腫瘍患者におけるネラチニブ(NKI-272),不可逆性汎ErbB受容体チロシンキナーゼ阻害剤の第I相研究
A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors
著者 (18件):
WONG Kwok-K.
(Harvard Medical School, Massachusetts)
,
FRACASSO Paula M.
(Washington Univ. School of Medicine, Missouri)
,
BUKOWSKI Ronald M.
(Clevland Clinic Foundation, Ohio)
,
LYNCH Thomas J.
(Massachusetts General Hospital, Massachusetts)
,
MUNSTER Pamela N.
(H. Lee Moffitt Cancer Center, Florida)
,
SHAPIRO Geoffrey I.
(Harvard Medical School, Massachusetts)
,
JAENNE Pasi A.
(Harvard Medical School, Massachusetts)
,
EDER Joseph P.
(Harvard Medical School, Massachusetts)
,
NAUGHTON Michael J.
(Washington Univ. School of Medicine, Missouri)
,
ELLIS Matthew J.
(Washington Univ. School of Medicine, Missouri)
,
JONES Suzanne F.
(Sarah Cannon Res. Inst., Tennessee)
,
MEKHAIL Tarek
(Clevland Clinic Foundation, Ohio)
,
ZACHARCHUK Charles
(Wyeth Res., Massachusetts)
,
VERMETTE Jennifer
(Wyeth Res., Massachusetts)
,
ABBAS Richat
(Wyeth Res., Massachusetts)
,
QUINN Susan
(Wyeth Res., Massachusetts)
,
POWELL Christine
(Wyeth Res., Massachusetts)
,
BURRIS Howard A.
(Sarah Cannon Res. Inst., Tennessee)
資料名:
Clinical Cancer Research
(Clinical Cancer Research)
巻:
15
号:
7
ページ:
2552-2558
発行年:
2009年04月01日
JST資料番号:
W1296A
ISSN:
1078-0432
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)